T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Dollar Tree
DLTR
$24.7B
| $479M | 0.06% |
4,489,394
+3,856,171
| +609% | +$455M |
|
277
Pfizer
PFE
$150B
| $478M | 0.06% |
17,091,951
-8,048,018
| -32% | -$222M |
|
278
Kinder Morgan
KMI
$70.7B
| $476M | 0.06% |
23,943,743
+3,528,978
| +17% | +$67.3M |
|
279
Shell
SHEL
$249B
| $476M | 0.06% |
6,589,069
-126,009
| -2% | -$9.01M |
|
280
Rayonier
RYN
$6.47B
| $475M | 0.06% |
17,979,589
+18,859
| +0.1% | +$518K |
|
281
Canadian National Railway
CNI
$76.4B
| $473M | 0.06% |
4,003,605
+17,050
| +0.4% | +$2.13M |
|
282
Atmos Energy
ATO
$28.7B
| $471M | 0.06% |
4,038,520
+2,802,222
| +227% | +$327M |
|
283
Nu Holdings
NU
$65.5B
| $468M | 0.06% |
36,277,568
-432,559
| -1% | -$5.04M |
|
284
Biogen
BIIB
$30.9B
| $466M | 0.06% |
2,011,411
+421,782
| +27% | +$91.7M |
|
285
GoDaddy
GDDY
$11.6B
| $466M | 0.06% |
3,333,371
-322,623
| -9% | -$42.6M |
|
286
Procore
PCOR
$8.81B
| $458M | 0.05% |
6,900,152
-1,816,729
| -21% | -$126M |
|
287
Nike
NKE
$60.1B
| $452M | 0.05% |
6,000,982
-7,599,688
| -56% | -$706M |
|
288
Sun Communities
SUI
$14.4B
| $451M | 0.05% |
3,746,514
+443,710
| +13% | +$52.7M |
|
289
Copart
CPRT
$26.8B
| $450M | 0.05% |
8,317,423
+1,456,141
| +21% | +$79.5M |
|
290
Zebra Technologies
ZBRA
$17.9B
| $448M | 0.05% |
1,449,846
+76,054
| +6% | +$23.1M |
|
291
Yum China
YUMC
$16.4B
| $446M | 0.05% |
14,464,261
-2,280,603
| -14% | -$83.5M |
|
|
RNAM
292
DELISTED
Avidity Biosciences
RNAM
| $446M | 0.05% |
10,916,626
+3,487,519
| +47% | +$100M |
|
293
TotalEnergies
TTE
$194B
| $446M | 0.05% |
6,681,950
-3,314,792
| -33% | -$236M |
|
294
Microchip Technology
MCHP
$43.1B
| $441M | 0.05% |
4,823,641
+295,932
| +7% | +$27.1M |
|
295
Ferrari
RACE
$71.6B
| $439M | 0.05% |
1,074,363
-406,495
| -27% | -$169M |
|
296
AT&T
T
$166B
| $437M | 0.05% |
22,848,572
-538,140
| -2% | -$9.36M |
|
|
HOLX
297
DELISTED
Hologic
HOLX
| $436M | 0.05% |
5,876,175
-421,022
| -7% | -$31.6M |
|
298
Celsius Holdings
CELH
$6.99B
| $436M | 0.05% |
7,630,775
+4,828,511
| +172% | +$365M |
|
299
Parker-Hannifin
PH
$135B
| $433M | 0.05% |
855,426
+658,466
| +334% | +$353M |
|
300
Arista Networks
ANET
$265B
| $430M | 0.05% |
4,912,528
+687,696
| +16% | +$51.1M |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.